How are EW straddle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the EW straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 29.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$547.98 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a EW straddle?

The breakeven for the EW straddle priced on this page is roughly $76.68 and $88.33 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current EW market-implied 1-standard-deviation expected move is approximately 8.43%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current EW implied volatility affect this straddle?

EW ATM IV is at 29.40% with IV rank near 28.83%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

EW Straddle Strategy

EW (Edwards Lifesciences Corporation), in the Healthcare sector, (Medical - Devices industry), listed on NYSE.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors.

EW (Edwards Lifesciences Corporation) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $46.86B, a trailing P/E of 43.14, a beta of 0.87 versus the broader market, a 52-week range of 72.3-87.89, average daily share volume of 5.0M, a public-listing history dating back to 2000, approximately 16K full-time employees. These structural characteristics shape how EW stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.87 places EW roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 43.14 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.

What is a straddle on EW?

A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.

Current EW snapshot

As of May 15, 2026, spot at $81.61, ATM IV 29.40%, IV rank 28.83%, expected move 8.43%. The straddle on EW below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this straddle structure on EW specifically: EW IV at 29.40% is on the cheap side of its 1-year range, which favors premium-buying structures like a EW straddle, with a market-implied 1-standard-deviation move of approximately 8.43% (roughly $6.88 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated EW expiries trade a higher absolute premium for lower per-day decay. Position sizing on EW should anchor to the underlying notional of $81.61 per share and to the trader's directional view on EW stock.

EW straddle setup

The EW straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With EW near $81.61, the first option leg uses a $82.50 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed EW chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 EW shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$82.50	$2.48
Buy 1	Put	$82.50	$3.35

EW straddle risk and reward

Net Premium / Debit: -$582.50
Max Profit (per contract): Unbounded
Max Loss (per contract): -$547.98
Breakeven(s): $76.68, $88.33
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.

EW straddle payoff curve

Modeled P&L at expiration across a range of underlying prices for the straddle on EW. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$7,666.50
$18.05	-77.9%	+$5,862.17
$36.10	-55.8%	+$4,057.84
$54.14	-33.7%	+$2,253.51
$72.18	-11.6%	+$449.17
$90.23	+10.6%	+$190.16
$108.27	+32.7%	+$1,994.49
$126.31	+54.8%	+$3,798.82
$144.36	+76.9%	+$5,603.15
$162.40	+99.0%	+$7,407.48

When traders use straddle on EW

Straddles on EW are pure-volatility plays that profit from large moves in either direction; traders typically buy EW straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.

EW thesis for this straddle

The market-implied 1-standard-deviation range for EW extends from approximately $74.73 on the downside to $88.49 on the upside. A EW long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current EW IV rank near 28.83% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on EW at 29.40%. As a Healthcare name, EW options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to EW-specific events.

EW straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. EW positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move EW alongside the broader basket even when EW-specific fundamentals are unchanged. Always rebuild the position from current EW chain quotes before placing a trade.

Frequently asked questions

What is a straddle on EW?: A straddle on EW is the straddle strategy applied to EW (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With EW stock trading near $81.61, the strikes shown on this page are snapped to the nearest listed EW chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are EW straddle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the EW straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 29.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$547.98 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a EW straddle?: The breakeven for the EW straddle priced on this page is roughly $76.68 and $88.33 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current EW market-implied 1-standard-deviation expected move is approximately 8.43%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a straddle on EW?: Straddles on EW are pure-volatility plays that profit from large moves in either direction; traders typically buy EW straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
How does current EW implied volatility affect this straddle?: EW ATM IV is at 29.40% with IV rank near 28.83%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.